478 related articles for article (PubMed ID: 27225288)
1. Initial Experience With High-Risk Patients Excluded From Clinical Trials: Safety of Short-Term Anticoagulation After Left Atrial Appendage Closure Device.
Barakat AF; Hussein AA; Saliba WI; Bassiouny M; Tarakji K; Kanj M; Jaber W; Rodriguez LL; Grimm R; Hussain MS; Russman A; Uchino K; Wisco D; Rasmussen P; Bain M; Vargo J; Zuccaro G; Gottesman D; Lindsay BD; Wazni OM
Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27225288
[TBL] [Abstract][Full Text] [Related]
2. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
3. Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage.
Hutt E; Wazni OM; Saliba WI; Kanj M; Tarakji KG; Aguilera J; Barakat AF; Rasmussen P; Uchino K; Russman A; Hussain S; Wisco D; Kapadia S; Lindsay BD; Hussein AA
Heart Rhythm; 2019 May; 16(5):663-668. PubMed ID: 30521942
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry.
Mazzone P; D'Angelo G; Regazzoli D; Molon G; Senatore G; Saccà S; Canali G; Amellone C; Turri R; Bella PD
J Interv Card Electrophysiol; 2018 Jun; 52(1):47-52. PubMed ID: 29525913
[TBL] [Abstract][Full Text] [Related]
6. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device.
Enomoto Y; Gadiyaram VK; Gianni C; Horton RP; Trivedi C; Mohanty S; Di Biase L; Al-Ahmad A; Burkhardt JD; Narula A; Janczyk G; Price MJ; Afzal MR; Atoui M; Earnest M; Swarup V; Doshi SK; van der Zee S; Fisher R; Lakkireddy DR; Gibson DN; Natale A; Reddy VY
Heart Rhythm; 2017 Jan; 14(1):19-24. PubMed ID: 27771552
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
8. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
[TBL] [Abstract][Full Text] [Related]
9. Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
Bonnet G; Salaun E; Pankert M; Cuisset T; Bonnet JL
Arch Cardiovasc Dis; 2016 Dec; 109(12):689-695. PubMed ID: 27594651
[TBL] [Abstract][Full Text] [Related]
10. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.
Calvo N; Salterain N; Arguedas H; Macias A; Esteban A; García de Yébenes M; Gavira JJ; Barba J; García-Bolao I
Europace; 2015 Oct; 17(10):1533-40. PubMed ID: 25935163
[TBL] [Abstract][Full Text] [Related]
11. Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device.
Kaneko H; Neuss M; Weissenborn J; Butter C
Heart Vessels; 2017 Sep; 32(9):1137-1143. PubMed ID: 28477098
[TBL] [Abstract][Full Text] [Related]
12. Left atrial appendage closure device implantation in patients at very high risk for stroke.
Hutt E; Wazni OM; Kaur S; Saliba WI; Tarakji KG; Kapadia S; Aguilera J; Barakat AF; Abdallah M; Jaber W; Rasmussen P; Hussain S; Uchino K; Wisco D; Lindsay BD; Kanj M; Hussein AA
Heart Rhythm; 2020 Jan; 17(1):27-32. PubMed ID: 31302250
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous left atrial appendage closure for stroke prevention.
De Backer O; Loupis AM; Ihlemann N; Vejlstrup NG; Søndergaard L; Franzen OW
Dan Med J; 2014 Aug; 61(8):A4879. PubMed ID: 25162439
[TBL] [Abstract][Full Text] [Related]
14. [Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: is left atrial appendage closure an alternative for anticoagulation?].
Boersma LVA; Rensing BJWM; Wintgens LI; Klaver M; Swaans MJ
Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040296
[TBL] [Abstract][Full Text] [Related]
15. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
López-Mínguez JR; Nogales-Asensio JM; Infante De Oliveira E; De Gama Ribeiro V; Ruiz-Salmerón R; Arzamendi-Aizpurua D; Costa M; Gutiérrez-García H; Fernández-Díaz JA; Martín-Yuste V; Rama-Merchán JC; Moreno-Gómez R; Benedicto-Buendía A; Íñiguez-Romo A
Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):449-455. PubMed ID: 29754808
[TBL] [Abstract][Full Text] [Related]
16. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
[TBL] [Abstract][Full Text] [Related]
18. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
[TBL] [Abstract][Full Text] [Related]
19. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
[TBL] [Abstract][Full Text] [Related]
20. First results of the Brazilian Registry of Percutaneous Left Atrial Appendage Closure.
Guérios ÊE; Chamié F; Montenegro M; Saad EB; Brito FS; Caramori PA; Simões LC; Oliveira FRA; Giuliano LC; Tavares CMDF
Arq Bras Cardiol; 2017 Nov; 109(5):440-447. PubMed ID: 29069203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
